Barclays raised the firm’s price target on Universal Health to $198 from $189 and keeps an Equal Weight rating on the shares as part of a Q2 earnings preview for the managed care space.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Universal Health upgraded to Outperform from Neutral at Baird
- Universal Health price target raised to $186 from $182 at JPMorgan
- Universal Health initiated with a Neutral at Baird
- Early notable gainers among liquid option names on May 29th
- Rubrik and Marex Group initiated: Wall Street’s top analyst calls